Literature DB >> 8290317

[Epidemiological pattern of the resistance of 153 Salmonella strains (S. typhi excluded) isolated in a Tunisian pediatric unit from 1985 to 1990].

A Ben Hassen1, M Bejaoui, M R Lakhoua, S Ben Redjeb.   

Abstract

Since 1985 to 1990, 153 isolates of non typhoidic Salmonella were recovered from pediatric unit of the Charles Nicolle Hospital in Tunis. The epidemiological profile of these isolates was established according to the biochemical and serological characterizations, the antibiotic susceptibility patterns (disk diffusion method) to betalactams and aminoglycosides. 127 isolates of Salmonella spp were from stools and 22 from blood cultures. The main serotypes were S. ser. Wien (108 isolates) and S. ser. Typhimurium (21). A sample of 50 isolates was selected among the different resistance phenotypes for determination of MICs and betalactamase identification by isolelectro-focusing (36 isolates). All of them were resistant to ampicillin and carbenicillin but variable for cephaloridine. Since 1986 appeared the resistance to cefotaxime and in 1990 all the S. ser. Wien isolates were resistant to the 4 betalactams tested including cefotaxime associated to streptomycin, kanamycin, gentamicin, tobramycin and amikacin. All of them had a high level of resistance to amoxicillin and gentamicin (mean MICs > 2048 and > 512 mg/l). The mean MIC of cefotaxime was 43.2 mg/l for S. ser. Wien, 64mg/l for S. ser. Typhimurium and decreased to 1.9 and 0.12 mg/l in combination with 1 mg/l of clavulanic acid. The beta-lactam resistance was mediated to enzymatic mechanism, at first the betalactamase of TEM-1 type alone, then associated to extended-spectrum betalactamase, mainly type SHV-2 since 1986, and other new types in 1990. They were under the control of plasmids with different sizes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8290317

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  6 in total

1.  Survey and molecular genetics of SHV beta-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12.

Authors:  M T Nüesch-Inderbinen; F H Kayser; H Hächler
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

2.  In vivo acquisition of extended-spectrum beta-lactamase in Salmonella enteritidis during antimicrobial therapy.

Authors:  F Barguellil; C Burucoa; A Amor; J L Fauchère; C Fendri
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-08       Impact factor: 3.267

3.  Distribution of extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae in Vietnam.

Authors:  Van Cao; Thierry Lambert; Duong Quynh Nhu; Huynh Kim Loan; Nguyen Kim Hoang; Guillaume Arlet; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

Review 4.  Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections.

Authors:  John A Crump; Maria Sjölund-Karlsson; Melita A Gordon; Christopher M Parry
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

5.  Characterization of extended-spectrum beta-lactamase-producing Salmonella typhimurium by phenotypic and genotypic typing methods.

Authors:  R A Mhand; N Brahimi; N Moustaoui; N El Mdaghri; H Amarouch; F Grimont; E Bingen; M Benbachir
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

6.  CTX-M-5, a novel cefotaxime-hydrolyzing beta-lactamase from an outbreak of Salmonella typhimurium in Latvia.

Authors:  P A Bradford; Y Yang; D Sahm; I Grope; D Gardovska; G Storch
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.